Members Capital Advisors Inc’s AbbVie ABBV Stock Holding History

Members Capital Advisors Inc’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,354	Closed	-$251K	–	7
2025 Q2	$251K	Hold	1,354	–	–	0.29%	15
2025 Q1	$284K	Hold	1,354	–	–	0.33%	11
2024 Q4	$241K	Hold	1,354	–	–	0.22%	14
2024 Q3	$267K	Hold	1,354	–	–	0.31%	12
2024 Q2	$232K	Hold	1,354	–	–	0.27%	14
2024 Q1	$247K	Hold	1,354	–	–	0.7%	13
2023 Q4	$210K	Hold	1,354	–	–	0.6%	14
2023 Q3	$202K	Sell	1,354 -14,920	-92%	-$2.19M	0.25%	55
2023 Q2	$2.19M	Hold	16,274	–	–	2.24%	9
2023 Q1	$2.59M	Hold	16,274	–	–	1.87%	11
2022 Q4	$2.63M	Hold	16,274	–	–	1.89%	10
2022 Q3	$2.18M	Hold	16,274	–	–	1.72%	17
2022 Q2	$2.49M	Hold	16,274	–	–	1.8%	12
2022 Q1	$2.64M	Hold	16,274	–	–	1.69%	16
2021 Q4	$2.2M	Hold	16,274	–	–	1.13%	27
2021 Q3	$1.75M	Buy	16,274 +2,482	+18%	+$284K	0.95%	31
2021 Q2	$1.4M	Buy	+13,792	New	+$1.55M	0.87%	57

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Members Capital Advisors Inc's ABBV Position: Q3 2025 in Review

Members Capital Advisors Inc sold out of AbbVie (ABBV) in Q3 2025, closing a stake of 1,354 shares — an estimated $251K sold.

Members Capital Advisors Inc first reported a position in ABBV in Q2 2021 and held it in 17 quarters. The position peaked at $2.64M in Q1 2022. 3,906 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

Members Capital Advisors Inc reported no remaining AbbVie position as of Q3 2025 after selling out during the quarter.
Members Capital Advisors Inc sold 1,354 AbbVie shares in Q3 2025, an estimated $251K.
Members Capital Advisors Inc first reported a position in AbbVie in Q2 2021 and held it in 17 quarters.
Members Capital Advisors Inc's AbbVie position peaked at $2.64M in Q1 2022.
3,906 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on Members Capital Advisors Inc's 13F filing for Q3 2025, filed 24 Oct 2025.